Volume 26, Issue 5 (8-2019)
RJMS 2019, 26(5): 114-130 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
baaji K, Pezeshki Modares M, rajabi S. Overview on vascular tissue engineering: Progress and challenges. RJMS 2019; 26 (5) :114-130
URL: http://rjms.iums.ac.ir/article-1-5653-en.html
URL: http://rjms.iums.ac.ir/article-1-5653-en.html
, srajabi@royaninstitute.org
Abstract: (7523 Views)
Today, vascular diseases such as atherosclerosis are one of the leading causes of death in the world and the prevalence of it in older societies is rising. The current treatments for repair of cardiovascular function include organ transplantation, surgical reconstruction, mechanical or artificial devices, or the use of metabolic products. Although these methods are commonly used, they did not grow significantly due to the shortage of donors and transmission of infection complications, rejection tissue by the patient's body. Currently, many researches are underway in the field of tissue and medical engineering for the development of new artificial vessels for small diameter vessels. In general, it can be classified as a source of biomaterials for natural and synthetic (biodegradable and non-degradable) broad spectrum of chemical and mechanical properties. The main purpose of tissue engineering is the design of alternative materials in vitro condition using live cells in order to restore the physiological function of the patient's tissue, which is similar to the natural tissue lost. In fact, tissue engineering as an interdisciplinary approach involves incorporating the principles of engineering, cellular and molecular biology, and clinical medicine. The tissue engineering structures consist of three major components: cells, materials, and growth factors. In this article, a review of the biomaterials, fabrication of scaffold, cells, as well as clinical applications in vascular tissue engineering are presented herein.
Type of Study: review article |
Subject:
Biotechnology
References
2. References
3. 1. Song G, Rumma RT, Ozaki CK, Edelman ER, Chen CS. Vascular tissue engineering: progress, challenges, and clinical promise. Cell Stem Cell; 2018. 22(3):340–354.
4. 2. Carrabba M , Madeddu P. Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts. Frontiers in bioengineering and biotechnology; 2018. 6(41):1-12.
5. 3. Schneider K.H, Aigner P, Holnthoner W,
6. Monforte, X, Nürnberger S, Rünzler D ,et al. Decellularized human placenta chorion matrix as a favorable source of small-diameter vascular grafts. Acta Biomater; 2016. 29: 125–134.
7. 4. Http://www.salamatnews.com/news/226063.
8. 5. Liu RH, Ong CS, T Fukunishi, K Ong, N. Hibino. Review of vascular graft studies in large animal models, Tissue Eng; 2018.24(2): 133–143.
9. 6. Bertram U, Steiner D, Poppitz B, Dippold D, Köhn K, P Beier J, et al. Vascular tissue engineering: effects of integrating collagen into a PCL based nanofiber material. Biomed Res; 2017.1-11.
10. 7. Ravi S, Chaikof EL, Biomaterials for vascular tissue engineering. Regen. Med; 2010. 5(1): 107–120.
11. 8. Pashneh-Tala S, MacNeil Sh, Claeyssens F.The tissue-engineered vascular graft—past, present, and future. Tissue Eng. 2015. 22(1): 68–100.
12. 9. Kannan RY, Salacinski HJ, Butler PE, Hamilton G, Seifalian AM. Current status of prosthetic bypass grafts. Biomed. Mater. Res; 2005. 74(1):570–581.
13. 10. Chan AHP, Tanl RP, Michael PL, Bob SL, Vanags LZ, K CNg Martin,et al. Evaluation of synthetic vascular grafts in a mouse carotid grafting model. PLoS One; 2017.12(3): 1-15.
14. 11. Henry JJ D, Yu J, Wang A, Lee R, Fang J, Song Li, Engineering the mechanical and biological properties of nanofibrous vascular grafts for in situ vascular tissue engineering. Biofabrication; 2017. 9(3):1-12.
15. 12. Abbott WM, Callow A, W Moore, Rutherford R, Veith F, Weinberg S. Evaluation and performance standards for arterial prostheses. Vasc. Surg; 1993. 17(4): 746–756.
16. 13. Swartz DD, Andreadis S T. Animal models for vascular tissue-engineering. Opin. Biotechnol. 2013. 24(5): 916–925.
17. 14. Pankajakshan D, Agrawal DK. Scaffolds in tissue engineering of blood vessels, Can. J. Physiol. Pharmaco; 2010.88(9): 855–873.
18. 15. Herbert SP, Stainier DYR. Molecular control of endothelial cell behaviour during blood vessel morphogenesis, Nat. Rev. Mol. cell Biol. 2011.12(9). 551.
19. 16. Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis, Cell, 2011.146(6): 873–887.
20. 17. Nemeno-Guanzon JG. Trends in tissue engineering for blood vessels. Biomed Res; 2012.
21. 18. Vacanti J P, Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet;1999. 354: S32–S34.
22. 19. Hinderer S, Lee Layland S, Schenke-Layland K. ECM and ECM-like materials—biomaterials for alications in regenerative medicine and cancer therapy. Drug Deliv; 2016. 97 :260–269.
23. 20. Dimitrievska S, Niklason LE. Historical perspective and future direction of blood vessel developments. Cold Spring Harb. Perspect. Med; 2018. 8(2): 1-14.
24. 21. Sachlos E, Czernuszka JT. Making tissue engineering scaffolds work. the alication of solid freeform fabrication technology to the production of tissue engineering scaffolds. Eur Cell Mater; 2003. 5(29): 39–40.
25. 22. Park SA, Lee SH, Kim W. Fabrication of hydrogel scaffolds using rapid prototyping for soft tissue engineering. Macromol. Res; 2011.19(7): 694–698.
26. 23. Rustad KC, Sorkin M, Levi B, Longaker MT, Gurtner GC. Strategies for organ level tissue engineering. Organogenesis; 2010. 6(3): 151–157.
27. 24. Hibino N, McGillicuddy E, Matsumura G, Ichihara Y, Naito Y, Breuer C, et al. Late-term results of tissue-engineered vascular grafts in humans. Thorac Cardiovasc Surg; 2010. 139(2): 431–436.
28. 25. Dahl SL, Blum JL, Niklason LE. Bioengineered Vascular Grafts: Can We Make Them Off-the-Shelf?. Trends Cardiovasc Med; 2011. 21(3): 83–89.
29. 26. Tara S, Rocco KA, Hibino N, Sugiura T, Hirotsugu Kurobe, Breuer CK. Vessel bioengineering. Circ J; 2014. 78(1): 12–19.
30. 27. Badylak SF. The extracellular matrix as a biologic scaffold material. Biomaterials; 2007. 28(25): 3587–3593.
31. 28. Schmidt CE, Baier JM. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials; 2000. 21(22): 2215–2231.
32. 29. Sandusky GE. Jr, Badylak SF, Morff RJ, Johnson WD, Lantz G. Histologic findings after in vivo placement of small intestine submucosal vascular grafts and saphenous vein grafts in the carotid artery in dogs. Am J Pathol; 1992. 140(2): 317-324.
33. 30. Sandusky GE, Lantz GC, Badylak SF. Healing comparison of small intestine submucosa and ePTFE grafts in the canine carotid artery. J Surg Res; 1995. 58(4): 415–420.
34. 31. Quint C, Kondo Y, Manson RJ, Lawson JH, Dardik A, Niklason LE. Decellularized tissue-engineered blood vessel as an arterial conduit. Proc Natl Acad Sci; 2011.108(22):9214-9219.
35. 32. Rajabi-Zeleti S, Jalili-Firoozinezhad S, Azarnia M, Khayyatan F, Vahdat S, Nikeghbalian S. The behavior of cardiac progenitor cells on macroporous pericardium-derived scaffolds. Biomaterials; 2014. 35(3): 970–982.
36. 33. Catto V, Farè S, Freddi G, Tanzi MC. Vascular tissue engineering: recent advances in small diameter blood vessel regeneration. ISRN Vasc Med; 2014. 1-27.
37. 34. Couet F, Rajan N, Mantovani D. Macromolecular biomaterials for scaffold‐based vascular tissue engineering. Macromol Biosci; 2007. 7(5): 701–718.
38. 35. Wu GP, Wang XM, Lin LP, Chen SH, Wu QQ. Isolation and characterization of pepsin-solubilized collagen from the skin of black carp (Mylopharyngdon piceus). Adv. Biosci. Biotechnol; 2014. 5: 642-650.
39. 36. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science;1986. 231: 397–400.
40. 37. Berillis P. The role of collagen in the aorta’s structure. open Circ Vasc J; 2013. 6: 1-8.
41. 38. Dong C, Lv Y. Application of collagen scaffold in tissue engineering: recent advances and new perspectives. Polymers (Basel); 2016.8(42):1-20.
42. 39. Zhu C, Fan D, Wang Y. Human-like collagen/hyaluronic acid 3D scaffolds for vascular tissue engineering. Mat Sci Eng; 2014. 34(1): 393–401.
43. 40. Yeo GC, Mithieux SM, Weiss AS. The Elastin Matrix in Tissue Engineering and Regeneration. Curr Opin. Biomed Eng; 2018. 6: 27-32.
44. 41. Li S, Sengupta D, Chien S. Vascular tissue engineering: From in vitro to in situ. Wiley Interdiscip. Rev Syst Biol Med; 2014. 6: 61–76.
45. 42. Thottappillil N , Nair PD. Scaffolds in vascular regeneration: Current status. Vasc Health Risk Manag; 2015.11: 79–91.
46. 43. Panzavolta S, Gioffrè M, Letizia M, Gualandi C, Foroni L, Bigi A. Electrospun gelatin nanofibers : Optimization of genipin cross-linking to preserve fiber morphology after exposure to water, Acta Biomater; 2011.7( 4): 1702–1709.
47. 44. Hajiabbas M, Mashayekhan S, Nazaripouya A, Naji M, Hunkeler D, Rajabi Zeleti S, Sharifiaghdas F. Chitosan-gelatin sheets as scaffolds for muscle tissue engineering, Artif cells nanomedicine Biotechnol ; 2015. 43(2): 124–132.
48. 45. Pezeshki-modaress M, Mirzadeh H, Zandi M. Gelatin-GAG Electrospun Nano Fibrous Scaffold for Skin Tissue Engineering: Fabrication and Modeling of Process Parameters. Mat Sci Eng; 2014. 48: 704-712.
49. 46. Panzavolta S, Gioffrè M, Focarete ML, Gualandi C, Foroni L, Bigi A. Electrospun gelatin nanofibers: optimization of genipin cross-linking to preserve fiber morphology after exposure to water. Acta Biomat; 2011.7(4): 1702–1709.
50. 47. Huang Y, Onyeri S, Siewe M, Moshfeghian A, Madihally SV. In vitro characterization of chitosan–gelatin scaffolds for tissue engineering. Biomaterials; 2005. 26(36): 7616–7627.
51. 48. Pezeshki-Modaress M, Zandi M, Rajabi S. Tailoring the gelatin/chitosan electrospun scaffold for application in skin tissue engineering: an in vitro study. Prog Biomat; 2018. 7(3): 207–218.
52. 49. Zhang M, Li XH, Gong YD, Zhao NM, Zhang XF. Properties and biocompatibility of chitosan films modified by blending with PEG. Biomaterials; 2002. 23(13): 2641–2648.
53. 50. Mao JS, Zhao LG, Yin YJ, Yao KDe. Structure and properties of bilayer chitosan–gelatin scaffolds. Biomaterials; 2003. 24(6): 1067–1074.
54. 51. Remuzzi A, Mantero S, Colombo M, Marina Morigi, Binda E, Camozzi D, et al. Vascular smooth muscle cells on hyaluronic acid: culture and mechanical characterization of an engineered vascular construct. Tissue Eng; 2004. 10(5–6): 699–710.
55. 52. Pardue EL, Ibrahim S, Ramamurthi A. Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering. Organogenesis; 2008 4(4): 203–214.
56. 53. Ramamurthi A, Vesely I. Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials; 2005. 26(9): 999–1010.
57. 54. Jockenhoevel S, Zund G, Hoerstrup P, Khaled Chalabi S, Sachweh J, Demircan L, et al. Fibrin gel–advantages of a new scaffold in cardiovascular tissue engineering. Eur. Cardio-thoracic Sur; 2001. 19(4): 424–430.
58. 55. Neidert MR, Lee ES, Oegema TR, Tranquillo RT. Enhanced fibrin remodeling in vitro with TGF-β1, insulin and plasmin for improved tissue-equivalents. Biomaterials; 2002. 23(7): 3717–3731.
59. 56. Tschoeke B, Flanagan TC, Koch S, Harwoko MS, Deichmann T, Ellå V,et al. Tissue-engineered small-caliber vascular graft based on a novel biodegradable composite fibrin-polylactide scaffold. Tissue Eng Part A; 2009. 15(8): 1909–1918.
60. 57. Pankajakshan D, Philipose LP, Palakkal M, Krishnan K, LK Krishnan. Development of a fibrin composite‐coated poly (ε‐caprolactone) scaffold for potential vascular tissue engineering applications. Biomed Mat Res Part B; 2008. 87(2): 570–579.
61. 58. Parizek M, Novotná K , Bacakova L. The role of smooth muscle cells in vessel wall pathophysiology and reconstruction using bioactive synthetic polymers. Physiol Res; 2011.60: 419-437.
62. 59. Awad N, Niu H, Ali U, Morsi Y, Lin T. Electrospun fibrous scaffolds for small-diameter blood vessels. A Review Membranes; 2018. 8(1):1-26.
63. 60. Ravi S, Chaikof EL. Biomaterials for vascular tissue engineering. Regen Med; 2010. 5(1):107–120.
64. 61. Thottappillil N, Nair PD. Scaffolds in vascular regeneration : Current status Scaffolds in vascular regeneration : current status. Vasc Health Risk Manag; 2015.11:79-91.
65. 62. Gilding DK. AM Reed. Biodegradable polymers for use in surgery—polyglycolic/poly (actic acid) homo-and copolymers:1. Polymer; 1979.20(12): 1459–1464.
66. 63. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Isogai N, Langer R, et al. Creation of viable pulmonary artery autografts through tissue engineering,. Thorac Cardiovasc Surg; 1998. 115(3): 536–546.
67. 64. Hajiali H, Shahgasempour S, Naimi-Jamal MR, Peirovi H. Electrospun PGA/gelatin nanofibrous scaffolds and their potential alication in vascular tissue engineering. Int Nanomed; 2011. 6: 2133–2141.
68. 65. Pankajakshan D, Agrawal DK. Scaffolds in tissue engineering of blood vessels. Physiol Pharmacol; 2010. 873: 855–873.
69. 66. Kim K, Meiki Y, Zong X, Chiu J , Fang D , Seo YS, et al. Control of degradation rate and hydrophilicity in electrospun non-woven poly (D, L-lactide) nanofiber scaffolds for biomedical applications, Biomaterials; 2003. 24(27): 4977–4985.
70. 67. Thottappillil N , Nair PD. Scaffolds in vascular regeneration: current status, Vasc Health Risk Manag; 2015. 11: 79-91.
71. 68. Gugutkov D, Gustavsson J, Cantini M, Salmeron‐Sánchez M, Altankov G. Electrospun fibrinogen–PLA nanofibres for vascular tissue engineering. Tissue Eng Regen Med; 2017.11(10): 2774–2784.
72. 69. Góra A, Pliszka D, Mukherjee S, Ramakrishna S. Tubular tissues and organs of human body—Challenges in regenerative medicine. Nanosci Nanotechnol; 2016.16(1): 19–39.
73. 70. Iwai S, Sawa Y, Ichikawa H, Taketani S, Uchimura E, Chen G, et al. Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis. Thorac Cardiovas Surg; 2004. 128(3): 472–479.
74. 71. Hashi CK, Derugin N, Janairo R, Lee R, Schultz D, Lotz J, et al. Antithrombogenic modification of small-diameter microfibrous vascular grafts. Arterioscler Thromb Vasc Biol; 2010.30(8): 1621–1627.
75. 72. Zhao J, Qiu H, Chen D, Zhang W, Zhang D, Li M. International Journal of Biological Macromolecules Development of nanofibrous scaffolds for vascular tissue engineering. Biol Macromol; 2013. 56: 106–113.
76. 73. Motlagh D , Yang J, Lui KY, Webb AR, Ameer GA. Hemocompatibility evaluation of poly (glycerol-sebacate) in vitro for vascular tissue engineering. Biomaterials; 2006. 27: 4315–4324.
77. 74. Gao J, Crapo PM, Wang Y. Macroporous elastomeric scaffolds with extensive micropores for soft tissue engineering. Tissue Eng; 2006.12(4): 917–925.
78. 75. Lee KW, Wang Y. Elastomeric PGS scaffolds in arterial tissue engineering. J Vis Exp JoVE; 2011.50.
79. 76. Crapo PM, Gao J, Wang Y. Seamless tubular poly (glycerol sebacate) scaffolds: High‐yield fabrication and potential applications. Biomed Mat; 2008. 86(2): 354–363.
80. 77. Woodruff MA, Hutmacher DW. The return of a forgotten polymer—polycaprolactone in the 21st century. Prog Polym Sci; 2010. 35(10): 1217–1256.
81. 78. Nair LS, Laurencin CT. Biodegradable polymers as biomaterials. Prog Polym Sci; 2007. 32: 762–798.
82. 79. Drilling S, Gaumer J, Lannutti J. Fabrication of burst pressure competent vascular grafts via electrospinning: effects of microstructure. Biomed Mater Res Part A; 2009. 88(4): 923–934.
83. 80. McClure MJ, Sell SA, Ayres CE, Simpson DG, Bowlin GL. Electrospinning-aligned and random polydioxanone–polycaprolactone–silk fibroin-blended scaffolds: geometry for a vascular matrix. Biomed. Materials; 2009. 4: 1-13.
84. 81. Jeong S, Kim BS, WoongKang S, HyunKwon J Y, MooLee, Kim SH, et al. In vivo biocompatibilty and degradation behavior of elastic poly (l-lactide-co-ε-caprolactone) scaffolds, Biomaterials; 2004. 25(28): 5939–5946.
85. 82. InJeonga S, Hyun Kwonb J, Limb JI , Cho SW, Jungb Y, Sungb WJ et al. Mechano-active tissue engineering of vascular smooth muscle using pulsatile perfusion bioreactors and elastic PLCL scaffolds. Biomaterials; 2005. 26(12): 1405–1411.
86. 83. Boland ED, Coleman BD, Barnes CP, Simpson DG, Wnek GE, GL Bowlin. Electrospinning polydioxanone for biomedical applications. Acta Biomater; 2005.1(1): 115–123.
87. 84. Greisler HP, Ellinger J, Schwarcz TH, Golan J, Raymond RM, Kim DU. Arterial regeneration over polydioxanone prostheses in the rabbit. Arch Surg; 1987.122(6): 715–721.
88. 85. Syedain ZH, Meier LA, Bjork JW, Lee A, Tranquillo RT. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials; 2011. 32(3): 714–722.
89. 86. Poh M, Boyer M, Solan A, LMDahl S, Pedrotty D, Banik SSR, et al. Blood vessels engineered from human cells. Lancet; 2005. 365(9477): 2122–2124.
90. 87. Kaushal S, , Amiel GE, Guleseriani KJ, Shapira OZ ,Perry T ,Sutherland Fw, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med; 2001 7(9): 1035–1040.
91. 88. Liu JY, Swartz DD, Peng HF, Gugino SF, Russell JA, Andreadis ST. Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovasc Res; 2007. 75(3): 618–628.
92. 89. illman BW, Yazdani SK, Neff LP, Corriere MA, Christ GJ, Soker S, et al. Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture. Vasc Surg; 2012. 56(3): 783–793.
93. 90. Suwandi JS, Toes RE, Nikolic T, Roep BO. Inducing tissue specific tolerance in autoimmune disease with tolerogenic dendritic cells. Clin Exp Rheumatol; 2015. 33: 97–103.
94. 91. Bjork JW, Meier LA, Johnson SL, Syedain ZH, Tranquillo RT. Hypoxic Culture and Insulin Yield Improvements to Fibrin-Based Engineered Tissue. Tissue Eng. Part A; 2012. 18(7): 785–795.
95. 92. Chlupáč J, Filova E, Bačáková L. Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery. Physiol Res; 2009. (58): 119-139.
96. 93. Ross J, Hong Z, Willenbring B, Zeng L, Brett Isenberg, Lee E, et al. Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. Clin Invest; 2006.116(12): 3139–3149.
97. 94. Matsumura G, Miyagawa-Tomita S, Shin’Oka T., Ikada Y, H Kurosawa. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation; 2003.108(14): 1729–1734.
98. 95. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M, Verfaillie CM. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp. Hematol; 2002. 30: 896–904.
99. 96. Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci; 2000. 97(7): 3213–3218.
100. 97. Gong Z, Niklason LE. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells. (hMSCs). FASEB; 2008.22( 6): 1635–1648.
101. 98. Melero-Martin JM, Obaldia M De, Kang SY, Khan ZA, Yuan L, Oettgen P ,et al. Engineering robust and functional vascular networks in vivo with human adult and cord blood–derived progenitor cells. Circ Res; 2008. 103(2): 194–202.
102. 99. Mirza A, Hyvelin JM, Rochefort GY, Lermusiaux P, Antier D, Awede B, Bonnet P, et al. Undifferentiated mesenchymal stem cells seeded on a vascular prosthesis contribute to the restoration of a physiologic vascular wall. Vasc Surg; 2008. 47(6): 1313–1321.
103. 100. Harris LJ, Abdollahi H, Zhang P, McIlhenny S, Tulenko TN, DiMuzio PJ, Differentiation of adult stem cells into smooth muscle for vascular tissue engineering. J Surg Res; 2011. 168( 2):306–314
104. 101. Planat-Benard V, Silvestre J, Cousin B, André M, Nibbelink M, Tamarat R, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation; 2004 . 109 (5): 656–663.
105. 102. Zhang P, Moudgill N, Hager E, Tarola N, DiMatteo C, McIlhenny S, Tulenko T, et al. Endothelial differentiation of adipose-derived stem cells from elderly patients with cardiovascular disease. Stem Cells Dev; 2010. 20(6): 977–988.
106. 103. Nieponice A, Soletti L, Guan J, Hong Y, Gharaibeh B, M Maul T, et al. In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Eng Part A; 2010. 16(4): 1215–1223.
107. 104. Peng HF, Liu JY, Andreadis ST, and Swartz DD. Hair follicle-derived smooth muscle cells and small intestinal submucosa for engineering mechanically robust and vasoreactive vascular media. Tissue Eng. Part A; 2011.17(7): 981–990.
108. 105. Gao Y, Liu F, Zhang L, X Su, Liu JY, Y Li. Acellular blood vessels combined human hair follicle mesenchymal stem cells for engineering of functional arterial grafts. Ann Biomed Eng; 2014. 42(10): 2177–2189.
109. 106. Bajpai VK, Mistriotis P, Andreadis ST. Clonal multipotency and effect of long-term in vitro expansion on differentiation potential of human hair follicle derived mesenchymal stem cells. Stem Cell Res; 2012. 8(1):74–84.
110. 107. Reynolds AJ, Lawrence C, Cserhalmi-Friedman PB, Christiano AM, Jahoda CAB. Trans-gender induction of hair follicles. Nature; 1999. 402: 33-34.
111. 108. Mistriotis P, Andreadis ST. Hair Follicle: A Novel Source of Stem Cells for Cell and Gene Therapy. Emerging Trends in Cell and Gene Therapy; 2013. 19(4): 265-278.
112. 109. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell; 2006.126: 663–676.
113. 110. Stegemann JP, Kaszuba SN, Rowe SL. Advances in vascular tissue engineering using protein-based biomaterials. Tissue Eng; 2007. 13(11):2601–2613.
114. 111. Benrashid E, Christopher C. McCoy, M Youngwirth L, Kim J, JManson R, et al. Tissue engineered vascular grafts: Origins, development, and current strategies for clinical application. Methods;2016. 99: 13–19.
115. 112. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O’Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl Med; 2000. 343(13): 915–922.
116. 113. Heureux NL, Dusserre N, Konig G, Victor B, Keire P, Wight T,et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med ; 2006.12( 3): 361-365.
117. 114. Iwasaki, Kiyotaka, Kojima, Koji Kodama, Shohta,Paz, et al. Bioengineered three-layered robust and elastic artery using hemodynamically-equivalent pulsatile bioreactor. Circulation; 2008. 118 (14): S52–S57.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
